| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/01/2023 | Phio Pharmaceuticals Corp. | RXII | Payment of Exercise | Common stock, $0.0001 par value | 917 | $1.51 | $1.4k | | 10/01/2023 |
| 07/01/2023 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 1000 | $2.84 | $2.8k | | 06/30/2023 |
| 06/30/2023 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 1000 | $2.88 | $2.9k | | 06/30/2023 |
| 02/20/2023 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 11k | $0.00 | $0 | | 02/20/2023 |
| 12/14/2022 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 2k | $0.39 | $780 | | 12/14/2022 |
| 12/07/2022 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 2k | $0.39 | $780 | | 12/07/2022 |
| 12/05/2022 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 2k | $0.43 | $860 | | 12/05/2022 |
| 11/29/2022 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 215 | $0.40 | $86 | | 11/25/2022 |
| 11/25/2022 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 2.5k | $0.42 | $1k | | 11/25/2022 |
| 11/16/2022 | Phio Pharmaceuticals Corp. | RXII | Purchase | Series D Preferred Stock, $0.0001 par value | 1 | $1,750.00 | $1.8k | | 11/16/2022 |
| 10/01/2022 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 40k | $0.00 | $0 | | 10/01/2022 |
| 02/15/2022 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 10k | $0.00 | $0 | | 02/15/2022 |
| 03/01/2021 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 10k | $0.00 | $0 | | 03/01/2021 |
| 11/18/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 300k | $0.10 | $30k | | 11/18/2019 |
| 02/13/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock | 10k | $0.00 | $0 | | 02/13/2019 |
| 08/01/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common Stock | 10k | $0.00 | $0 | | 08/01/2018 |
| 02/01/2017 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock option (right to buy) | 2k | $0.63 | $1.3k | | 02/01/2017 |
| 08/26/2013 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 500 | $3.90 | $2k | | 08/26/2013 |
| 08/05/2013 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, par value $0.0001 | 500 | $4.13 | $2.1k | | 08/05/2013 |
| 08/05/2013 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, par value $0.0001 | 200 | $4.05 | $810 | | 08/05/2013 |
| 08/05/2013 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, par value $0.0001 | 100 | $4.01 | $401 | | 08/05/2013 |
| 08/05/2013 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, par value $0.0001 | 100 | $4.02 | $402 | | 08/05/2013 |
| 08/05/2013 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, par value $0.0001 | 100 | $4.05 | $405 | | 08/05/2013 |
| 06/07/2013 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock Option (right to buy) | 500k | $0.20 | $100k | | 06/07/2013 |